These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4743228)

  • 1. Short-term memory: facilitation and disruption with cholinergic agents.
    Alpern HP; Marriott JG
    Physiol Behav; 1973 Oct; 11(4):571-5. PubMed ID: 4743228
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic mechanisms and alterations in behavioral suppression as factors producing time-dependent changes in avoidance performance.
    Anisman H
    J Comp Physiol Psychol; 1973 Jun; 83(3):465-77. PubMed ID: 4715307
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroconvulsive shock induced impairment and enhancement of a learned escape response.
    Wiener NI
    Physiol Behav; 1970 Sep; 5(9):971-4. PubMed ID: 5522524
    [No Abstract]   [Full Text] [Related]  

  • 4. Relearning at different times after training as affected by centrally and peripherally acting cholinergic drugs in the mouse.
    Squire LR; Glick SD; Goldfarb J
    J Comp Physiol Psychol; 1971 Jan; 74(1):41-5. PubMed ID: 5163699
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of scopolamine and physostigmine with ECS and one trial learning.
    Davis JW; Thomas RK; Adams HE
    Physiol Behav; 1971 Mar; 6(3):219-22. PubMed ID: 5125477
    [No Abstract]   [Full Text] [Related]  

  • 6. Ontogenetic aspects of central cholinergic involvement in spontaneous alternation behavior.
    Egger GJ; Livesey PJ; Dawson RG
    Dev Psychobiol; 1973 Jul; 6(4):289-99. PubMed ID: 4793359
    [No Abstract]   [Full Text] [Related]  

  • 7. Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine.
    Bohdanecký Z; Jarvik ME
    Int J Neuropharmacol; 1967 May; 6(3):217-22. PubMed ID: 6037526
    [No Abstract]   [Full Text] [Related]  

  • 8. ECS dissociation of learning and one-way cross-dissociation with physostigmine and scopolamine.
    Gardner EL; Glick SD; Jarvik ME
    Physiol Behav; 1972 Jan; 8(1):11-5. PubMed ID: 4677196
    [No Abstract]   [Full Text] [Related]  

  • 9. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
    Raghavendra V; Chopra K; Kulkarni SK
    Neuropeptides; 1998 Oct; 32(5):417-21. PubMed ID: 9845001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired short-term memory resulting from postnatal undernutrition is attenuated by physostigmine.
    Castro CA; Rudy JW
    Behav Neural Biol; 1993 Nov; 60(3):282-5. PubMed ID: 8297326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholinergic system, amnesia and memory.
    Lewis DJ; Bregman NJ
    Physiol Behav; 1972 Mar; 8(3):511-4. PubMed ID: 5064483
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed matching-to-sample performance by rats in a new avoidance-motivated maze: response to scopolamine and fimbria-fornix lesions.
    Bresnahan EL; Wiser PR; Muth NJ; Ingram DK
    Physiol Behav; 1992 Apr; 51(4):735-46. PubMed ID: 1594672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
    Sharma AC; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):175-80. PubMed ID: 2161973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holeboard discrimination learning in mice.
    Kuc KA; Gregersen BM; Gannon KS; Dodart JC
    Genes Brain Behav; 2006 Jun; 5(4):355-63. PubMed ID: 16716205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of scopolamine and physostigmine on working and reference memory in pigeons.
    Santi A; Bogles J; Petelka S
    Behav Neural Biol; 1988 Jan; 49(1):61-73. PubMed ID: 3345192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice.
    Sharma AC; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):155-9. PubMed ID: 1828849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of centrally and peripherally acting cholinergic drugs on the short-term performance gradient following passive-avoidance training.
    Schneider AM; Kapp BS; Sherman WM
    Psychopharmacologia; 1970 Aug; 18(1):77-81. PubMed ID: 5523377
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).
    Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC
    Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats.
    Beckwith BE; Sandman CA; Hothersall D; Kastin AJ
    Physiol Behav; 1977 Jan; 18(1):63-71. PubMed ID: 905382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.